STAMFORD, CT, April 02, 2026 /24-7PressRelease/ — Stephen H. Liebowitz, DHA, MHA, has been included in Marquis Who’s Who. As in all Marquis Who’s Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account…
A new Development Control Plan (DCP) for University Hospital Galway, as well as an associated Strategic Assessment Review (SAR) has been completed and is approved by the HSE Board, the latest meeting of the Regional Health Forum heard last week.
Russia has administered the first personalized vaccine to a clinical patient, a man with stage three skin cancer Read Full Article at RT.com
Nvidia CEO Jensen Huang’s advice to workers scared of AI: You’re confusing your job with the tools you use to do it
QUEENSBURY, N.Y. — Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, will attend the Society of Interventional Radiology (SIR) 2026 Annual Scientific Meeting, taking place April 11โ15, 2026, in Toronto, Canada. At the event, Delcathโs Hepatic Delivery System for use in percutaneous…
TORONTO, April 01, 2026 (GLOBE NEWSWIRE) โ Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (โProfoundโ or the โCompanyโ), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue, is pleased to announce that the interventional MRI (โiMRIโ) TULSA Procedureโข will be highlighted in several presentations at the 2026…
TORONTO, April 01, 2026 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (โProfoundโ or the โCompanyโ), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue, is pleased to announce that the interventional MRI (โiMRIโ) TULSA Procedureโข will be highlighted in several presentations at the 2026…
John Lynch stood at a podium in Phoenix on Sunday and did something no NFL general manager has ever had to do: announce the results of a scientific investigation into whether his own facility was harming players.
The Emirate of Abu Dhabi has achieved a series of significant medical and scientific milestones during the first quarter of 2026, reflecting the rapid advancement of its healthcare ecosystem and reinforcing its position as a regional and global hub for medical innovation and advanced therapies, WAM reports.
A fresh set of stock calls from Nuvama has brought Gravita India, Kalpataru Projects, Dr Lal PathLabs, Motherson Sumi Wiring India and Welspun Corp into focus, with the brokerage reiterating ‘Buy’ ratings and pointing to strong earnings visibility backed by capacity expansion and robust order books. The reports list multiple company-specific triggers, including new business…